Dynamic Contrast-Enhanced MR Imaging in Detecting Local Tumor Progression after HIFU Ablation of Localized Prostate Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : To retrospectively evaluate the diagnostic performance of dynamic contrast-enhanced MR imaging (DCE-MRI)in detecting recurrent prostate cancer after HIFU of clinically localized cancer, as compared with T2-weighted imaging (T2WI). Materials and Methods: Twenty-six patients with increased prostate-specific antigen levels after HIFU were included in this study. All MR examinations were performed using T2WI and DCE-MRI, followed by transrectal ultrasound-guided biopsy. MRI and biopsy results were correlated in six prostate sectors. Residual or recurrent cancer after HIFU was defined as local tumor progression if biopsy results showed any cancer foci. Two independent readers interpreted the MR images. Results: Of 156 prostate sectors, 51 (33%) were positive for cancer in 17 patients. For detecting local tumor progression,the sensitivity of DCE-MRI and T2WI was 80% and 57% for reader 1 (P < 0.001) versus 84% and 61% for reader 2 (P <0.001), respectively. The specificity and overall accuracy between DCE-MRI and T2WI showed no statistical difference in both readers (P > 0.05). Interobserver agreement of DCE-MRI and T2WI was moderate and fair, respectively. Conclusion: For detecting local tumor progression of prostate cancer after HIFU, DCE-MRI was more sensitive than T2WI,with less interobserver variability.
Abstract
Purpose : To retrospectively evaluate the diagnostic performance of dynamic contrast-enhanced MR imaging (DCE-MRI)in detecting recurrent prostate cancer after HIFU of clinically localized cancer, as compared with T2-weighted imaging (T2WI). Materials and Methods: Twenty-six patients with increased prostate-specific antigen levels after HIFU were included in this study. All MR examinations were performed using T2WI and DCE-MRI, followed by transrectal ultrasound-guided biopsy. MRI and biopsy results were correlated in six prostate sectors. Residual or recurrent cancer after HIFU was defined as local tumor progression if biopsy results showed any cancer foci. Two independent readers interpreted the MR images. Results: Of 156 prostate sectors, 51 (33%) were positive for cancer in 17 patients. For detecting local tumor progression,the sensitivity of DCE-MRI and T2WI was 80% and 57% for reader 1 (P < 0.001) versus 84% and 61% for reader 2 (P <0.001), respectively. The specificity and overall accuracy between DCE-MRI and T2WI showed no statistical difference in both readers (P > 0.05). Interobserver agreement of DCE-MRI and T2WI was moderate and fair, respectively. Conclusion: For detecting local tumor progression of prostate cancer after HIFU, DCE-MRI was more sensitive than T2WI,with less interobserver variability.
참고문헌 (21)
- Aus G, "EAU guidelines on prostate cancer", Eur Urol, 48, pp.546~551 (2005)
- Aus G, "Current status of HIFU and cryotherapy in prostate cancer--a review", Eur Urol, 50, pp.927~934 (2006)
- Poissonnier L, "Control of prostate cancer by transrectal HIFU in 227 patients", Eur Urol, 51, pp.381~387 (2007)
- Forsythe K, "Intensitymodulated radiotherapy causes fewer side effects than threedimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer", Int J Radiat Oncol Biol Phys, 83, pp.630~635 (2012)
- Orsi F, "High intensity focused ultrasound ablation: a new therapeutic option for solid tumors", J Cancer Res Ther, 6, pp.414~420 (2010)
- Colombel M, "Principles and results of high-intensity focused ultrasound for localized prostate cancer", Prostate Cancer Prostatic Dis, 7, pp.289~294 (2004)
- Rebillard X, "Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer", J Endourol, 19, pp.693~701 (2005)
- Gelet A, "Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography", Urology, 63, pp.625~629 (2004)
- Rouviere O, "MRI appearance of prostate following transrectal HIFU ablation of localized cancer", Eur Urol, 40, pp.265~274 (2001)
- Kirkham AP, "MR imaging of prostate after treatment with highintensity focused ultrasound", Radiology, 246, pp.833~844 (2008)
- Kim CK, "MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer", AJR Am J Roentgenol, 190, pp.1180~1186 (2008)
- Ben Cheikh A, "MR detection of local prostate cancer recurrence after transrectal highintensity focused US treatment: preliminary results", J Radiol, 89, pp.571~577 (2008)
- Punwani S, "Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent disease", Br J Radiol, 85, pp.720~728 (2012)
- Goldberg SN, "Image-guided tumor ablation: standardization of terminology and reporting criteria", Radiology, 235, pp.728~739 (2005)
- Engelbrecht MR, "Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging", Radiology, 229, pp.248~254 (2003)
- Futterer JJ, "Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers", Radiology, 237, pp.541~549 (2005)
- Kim JK, "Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization", J Magn Reson Imaging, 22, pp.639~646 (2005)
- Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33, pp.159~174 (1977)
- Donahue KM, "Dynamic Gd- DTPA enhanced MRI measurement of tissue cell volume fraction", Magn Reson Med, 34, pp.423~432 (1995)
- Isebaert S, "Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology", J Magn Reson Imaging (2012)
- Ocak I, "Dynamic contrastenhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters", AJR Am J Roentgenol, 189, pp.849~ (2007)